Cell and gene therapies are opening new chapters for treating disease. By working with living cells and fine-tuning their ...

New research finds a new strategy for treating a deadly cancer by combining existing drugs to indirectly weaken tumor growth, with potential implications for other cancers.

The investigational KRAS G12D inhibitor zoldonrasib showed evidence of clinical activity and a favorable safety profile in ...

Researchers engineered a panel of drug-resistant NSCLC models using CRISPR gene editing and gene overexpression techniques.

New models can help researchers accelerate discovery of resistance pathwaysKey Takeaways Creating new models of ...

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced ...

What if your morning cup of coffee could do more than just help you start the day off right? Scientists are saying that one ...